Call Us: (513) 621-5112

 
 
 
 
 
 
Frequently Used Terms
 
 
Multicenter:

More than one research site is participating in the study.

International:

Sites from countries outside of the US are also participating.

Double-blind:

Neither the research site nor the participant know what treatment the patient is receiving (there are methods of "unblinding" if medically necessary).

Randomized:

The treatment group the patient is assigned to is done randomly, like tossing a coin.

Placebo Controlled:

One treatment group consists of placebo, an inactive substance.

Crossover Design:

Patients will be changed from one treatment to another during the study as part of the study design.

Sponsor:

The company or agency of the US government (such as the National Institutes of Health (NIH)) that provides funding for the study.
 

I Want to Participate >>



Study Participants
 

Contact Us Today!

     
 
 
 

CONTACT US
NEWS & ARTICLES
Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

Springdale
375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
C-Diff: Could a vaccine prevent this contagious killer?
Tuesday, July 11, 2017

Clostridium difficile (C-diff) is a bacterial infection that causes abdominal pain, fever and diarrhea. The symptoms may range from mild to severe and can lead to death.

 
 
 



Copyright © 2017. STERLING RESEARCH. All Rights Reserved